登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JMII，2月4日，Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-10

  • Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV

    Ping-IngLee, Po-RenHsueh

    https://doi.org/10.1016/j.jmii.2020.02.001

    Coronaviruses are enveloped RNA viruses that are widely detected in mammals and birds, and commonly denoted in etiologies of upper respiratory tract infections in humans.1, 2, 3 Two potentially dangerous zoonotic coronaviruses have emerged in the past two decades. The severe acute respiratory syndrome coronavirus (SARS-CoV), originating from China, was responsible for the first outbreak that extended from 2002 to 2003. The second outbreak occurred in 2012 in the Middle East and was caused by the Middle East respiratory syndrome coronavirus (MERS-CoV).

  • 原文来源：https://www.sciencedirect.com/science/article/pii/S1684118220300116?via%3Dihub
12浏览量
原文链接
相关报告

  • 《2月4日_人畜共患冠状病毒的新威胁-从SARS和MERS到2019-nCoV》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-11
    • 1.时间：2020年2月4日 2.机构或团队：台湾大学儿童医院、台湾大学医学院 3.事件概要： 中国台湾大学儿童医院等于2020年2月4日在Journal of Microbiology, Immunology and Infection上发表题为“Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV”研究观点的文章。 冠状病毒是在哺乳动物和鸟类中广泛发现的有包膜的RNA病毒。过去二十年中，出现了两种人畜共患型冠状病毒，2002年至2003年中国首次爆发的严重急性呼吸系统综合症冠状病毒（SARS-CoV）和2012年中东地区的中东呼吸综合症冠状病毒（ MERS-CoV）。2019年底中国武汉第三次暴发了2019年新型冠状病毒（2019-nCoV）。蝙蝠被认为是2019-nCoV可能的主要宿主，中间宿主尚不明确。受感染的个体无症状或轻度症状时，传播链的鉴定及接触者追踪将更加复杂。 冠状病毒使用刺突蛋白附着于宿主细胞。有效的人际传播包括液滴转移、直接接触和间接接触，人际传播需要高感染剂量，与被感染者密切接触是前提条件。三种人畜共患的冠状病毒暴发都与重症肺炎有关。2019-nCoV的致病性可能低于MERS-CoV和SARS-CoV。2019-nCoV病毒可能在人际有效传播并带来大流行的可能性。目前，中国仅对克力芝（洛匹那韦/利托那韦，lopinavir / ritonavir）的功效和潜力进行了研究。抗2019-nCoV感染的其它潜在药物，包括核苷类似物、神经氨酸酶抑制剂、瑞德西韦（remdesivir）、umifenovir（盐酸阿比朵尔）、替诺福韦（TDF）和拉米夫定（3TC），还有几种中药。最近有报道瑞德西韦用于治疗美国首例由2019-nCoV引起的肺炎的临床疗效，但是这些数据来自研究的初步阶段，不足以支持临床应用于2019-nCoV感染的治疗。遏制2019-nCoV病毒快速传播可为有效疫苗和抗病毒剂的开发争取时间。 4.附件： 链接https://www.sciencedirect.com/science/article/pii/S1684118220300116?via%3Dihub
    75浏览量
    原文链接

  • 《SSRN，2月4日，Epidemic Prediction of 2019-nCoV in Hubei Province and Comparison with SARS in Guangdong Province》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-06
    • Epidemic Prediction of 2019-nCoV in Hubei Province and Comparison with SARS in Guangdong Province 16 Pages Posted: 4 Feb 2020 Yuxiao Bai Xidian University Xun Nie Xidian University Chenxin Wen Xidian University Date Written: February 4, 2020 Abstract Since the first case of new coronavirus (2019-nCoV) pneumonia appeared in Wuhan, the virus has spread very rapidly in China on December 31st, with Hubei Province having the most severe epidemic situation. As of 24:00 on February 2nd, the cumulative number of confirmed cases in Hubei Province has reached up to 11,177. In this paper, we select the epidemic situation in Hubei Province as the research object to establish the SEIQDR model of infectious diseases. The parameters are determined from the existing data to predict the trend of the cumulative number of confirmed diagnoses, and the parameters are adjusted according to the prevention and control measures as well as possible changes. In comparison with Guangdong Province, where the SARS epidemic originated, it was concluded that the new coronavirus epidemic far exceeds the SARS epidemic in terms of infection rate and deaths. But thanks to the timely and effective prevention and control measures taken by the country, currently the epidemic is under control, and we predict the end of the epidemic is about 60 days earlier than the SARS virus. The total number of confirmed diagnoses in Hubei Province is 26,701 (ranges from 24,355 to 32,406), and the rapid growth period is expected to be from January 27th to February 10, and the epidemic will grow slowly after February 22nd. The growth is expected to stop on March 30th (ranges from March 26th to April 19th). *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    156浏览量
    原文链接